The BriefBrief · Intelligence, not news.
Download on the App Store Get it on Google Play
Top Stories World US Deutschland Россия Sports Business Weather Local Messages My Briefs
Event Brief
Mar 18, 2026 at 2:04 PM ET

FDA Approves J&J's New Psoriasis Pill

By The BriefBrief
Johnson & Johnson's oral psoriasis treatment gains FDA approval, competing with popular injectable options.
WHO: Johnson & Johnson
WHAT: FDA approves psoriasis pill
WHEN: Mar 18, 2026 at 1:17 PM ET
WHERE: USA
WHY: To provide a new oral treatment option for psoriasis patients.
Sources (1): CNBC Top News

How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.

Know more. Read less.

The BriefBrief — updated continuously, every category, every day.
Final defendant sentenced in Zaria McKeever murder case
Zaria Mckeever May 1, 2026 at 3:23 PM ET
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota May 1, 2026 at 3:23 PM ET

Page 21472 of 21472

Same format. Every time.

Continue reading — sign in or create a free account with

G Google  Apple or email